FindTrial
Sign In

Development of Early Predictive Biomarkers and Prediction Technologies for Postpartum Glucose Dysregulation in Gestational Diabetes Mellitus

Development of Early Predictive Biomarkers and Prediction Technologies for Postpartum Glucose Dysregulation in Gestational Diabetes Mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128162
Enrollment
Unknown
Registered
2026-07-15
Start date
2026-01-14
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus, Diabetes Mellitus

Interventions

Observation group:NONE

Sponsors

Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women with GDM who have established prenatal records, received regular antenatal care, and delivered at our hospital; 2. Singleton pregnancy.

Exclusion criteria

Exclusion criteria: 1. Multiple pregnancy; 2. History of hepatitis, nephritis, or infectious diseases; 3. Pre-existing metabolic diseases before pregnancy (e.g., diabetes mellitus); 4. Mental disorders; 5. Incomplete clinical data; 6. Inability or unwillingness to participate in follow-up visits.

Design outcomes

Primary

MeasureTime frame
OGTT Blood sugar;Metabolomic changes;—

Secondary

MeasureTime frame
Model diagnostic performance: cutoff values, sensitivity, specificity, positive predictive value, negative predictive value, etc.;—

Countries

China

Contacts

Public ContactGuanghui Li

Beijing Obstetrics and Gynecology Hospital, Capital Medical University

liguanghui2007@163.com+86 10 5227 3110

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026